(Total Views: 289)
Posted On: 10/09/2019 11:18:10 AM
Post# of 150989
Yes, I figured it was our original manufacturer. I thought the language changed, but just compared to the 10-K and it matches identical....so no changes since Samsung was announced.
Possibly they are going with their current CMO initially to meet the demands and avoid the $8.3M penalty along with the added benefit they are US based and history producing leronlimab. Likely nothing significant, just looking forward to approval and would hate to see demand outpace supply (wouldn't be the worst problem to have though).
Possibly they are going with their current CMO initially to meet the demands and avoid the $8.3M penalty along with the added benefit they are US based and history producing leronlimab. Likely nothing significant, just looking forward to approval and would hate to see demand outpace supply (wouldn't be the worst problem to have though).
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼
